Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viemed Healthcare (VMD) Total Debt (2019 - 2025)

Historic Total Debt for Viemed Healthcare (VMD) over the last 7 years, with Q3 2025 value amounting to $21.1 million.

  • Viemed Healthcare's Total Debt rose 37375.62% to $21.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.1 million, marking a year-over-year increase of 37375.62%. This contributed to the annual value of $4.0 million for FY2024, which is 4348.32% down from last year.
  • As of Q3 2025, Viemed Healthcare's Total Debt stood at $21.1 million, which was up 37375.62% from $4.3 million recorded in Q2 2025.
  • In the past 5 years, Viemed Healthcare's Total Debt registered a high of $21.1 million during Q3 2025, and its lowest value of $3.9 million during Q1 2025.
  • Moreover, its 5-year median value for Total Debt was $6.3 million (2021), whereas its average is $7.4 million.
  • Its Total Debt has fluctuated over the past 5 years, first crashed by 5506.09% in 2024, then surged by 37375.62% in 2025.
  • Over the past 5 years, Viemed Healthcare's Total Debt (Quarter) stood at $5.8 million in 2021, then fell by 25.32% to $4.3 million in 2022, then surged by 63.71% to $7.1 million in 2023, then plummeted by 43.48% to $4.0 million in 2024, then soared by 428.74% to $21.1 million in 2025.
  • Its last three reported values are $21.1 million in Q3 2025, $4.3 million for Q2 2025, and $3.9 million during Q1 2025.